Krystal Biotech, Inc. KRYS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $55.93M+56.5% | $51.4M+13.0% | $79.37M+192% | $38.33M+146% | $35.73M+3,734% | ||
| $1.52M+7.9% | $1.56M+14.5% | $1.4M+7.7% | $1.3M-27.8% | $1.41M-1.2% | ||
| $13.61M+1.0% | $13.76M+3.1% | $13.15M-1.2% | $14.12M+7.3% | $13.48M+44.9% | ||
| -$58K+96.1% | —— | $17.92M— | $8.18M-85.6% | -$1.49M-134% | ||
| $243K-82.6% | $1.06M-83.8% | $4.71M+28.1% | —— | $1.4M-37.7% | ||
| $1.02M+12.8% | —— | —— | $4.12M+426% | $906K+24.6% | ||
| -$6.31M-271% | $5.79M-22.7% | $5.92M— | $0— | $3.7M+172% | ||
| $1.7M-50.5% | —— | $1.35M— | —— | $3.43M+6,702% | ||
| $1.44M+169% | $562K-14.6% | $350K+102% | $834K+41.8% | $534K— | ||
| $136K-77.9% | $289K— | —— | $76K-76.8% | $614K+358% | ||
| $204K-8.9% | $200K+4.7% | $209K+11.2% | $194K+4.3% | $224K+23.1% | ||
| $80.38M+160% | $77.51M+46.7% | $39.66M-32.6% | $52.73M— | $30.97M+94.9% | ||
| $7.15M+15.2% | $2.14M+167% | $1.7M+62.9% | $1.9M+68.3% | $6.2M+392% | ||
| $160.03M+16.1% | $72.46M-49.5% | $98.37M-12.6% | $113.9M+0.4% | $137.81M+56.0% | ||
| $103.6M+16.7% | $85.76M+41.8% | $95.79M+20.9% | $105.28M+10.6% | $88.81M+39.6% | ||
| $0-100% | —— | —— | —— | $435K— | ||
| -$63.58M-16.1% | —— | -$4.29M+87.5% | -$10.53M+45.6% | -$54.77M-111% | ||
| $6.5M+345% | -$6.97M— | $3.71M— | $1.8M+111% | $1.46M-90.8% | ||
| —— | —— | —— | —— | —— | ||
| -$10.46M+16.1% | $15.67M+545% | —— | —— | -$12.47M-218% | ||
| -$1.33M-878% | —— | —— | $1.06M+414% | $171K-8.6% | ||
| $5.01M+114% | $103.7M+456% | $38.78M+37.6% | $45.06M+441% | -$36.1M-5,424% | ||
| $627K+56.8% | $1.8M+249% | $18K-99.4% | $13.46M+572% | $400K— | ||
| -$576K-27.2% | -$637K-273% | -$325K+24.6% | $917K+404% | -$453K+43.5% | ||
| $1.52M+7.9% | $1.56M+14.5% | $1.4M+7.7% | $1.3M-27.8% | $1.41M-1.2% | ||
| $0+100% | —— | —— | —— | -$31.25M-350% | ||
| -$6.31M-271% | $5.79M-22.7% | $5.92M— | $0— | $3.7M+172% | ||
| $12.69M+19.7% | $2.31M-68.2% | $4.12M-47.2% | $4.23M-59.5% | $10.6M+99.6% | ||
| -$227K-66.9% | -$165K+23.6% | -$155K+26.5% | -$122K+41.1% | -$136K+31.7% | ||
| $1.44M+169% | $562K-14.6% | $350K+102% | $834K+41.8% | $534K— | ||
| $1.7M-50.5% | —— | $1.35M— | —— | $3.43M+1,519% | ||
| -$3.37M-636% | $2.29M+135% | —— | —— | -$457K— | ||
| $204K-8.9% | $200K+4.7% | $209K+11.2% | $194K+4.3% | $224K+23.1% | ||
| $529K-64.8% | $404K-75.4% | $1.29M-17.5% | $2.75M+67.3% | $1.5M+23.8% | ||
| $103.6M+16.7% | —— | —— | $105.28M+10.6% | $88.81M+39.6% | ||
| $0-100% | —— | —— | —— | $435K— | ||
| $1.22M-12.8% | $2.44M+1,092% | —— | —— | $1.4M-83.5% | ||
| $0-100% | —— | —— | —— | $1.8M— | ||
| $73.23M+196% | $75.37M+44.8% | $37.96M-34.3% | $50.83M— | $24.77M+69.3% | ||
| $73.23M+196% | $75.37M+44.8% | $37.96M-34.3% | $50.83M— | $24.77M+69.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Krystal Biotech, Inc. generate?
- Krystal Biotech, Inc. (KRYS) generated $250.3M in operating cash flow over the trailing twelve months.
- What is Krystal Biotech, Inc.'s free cash flow?
- After $12.9M of capital expenditures, Krystal Biotech, Inc.'s free cash flow was $237.4M over the trailing twelve months, up 76.3% year over year.
- Where does Krystal Biotech, Inc.'s cash flow data come from?
- Every line is extracted from Krystal Biotech, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
